Preeclampsia's hidden heart risk: can exercise testing catch it early?
NCT ID NCT06741436
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study aims to find early signs of heart failure in women who had preeclampsia, a pregnancy complication involving high blood pressure. Researchers will use exercise stress tests and heart imaging to compare 250 women with a history of preeclampsia to 250 women with normal pregnancies. The goal is to identify who is at highest risk for future heart problems and understand the underlying causes.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify women at high risk for heart failure after preeclampsia, allowing earlier interventions to prevent or delay the disease.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to direct clinical changes, and the findings might not apply to all women or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE PRESERVED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we stop early artery aging in kids with kidney disease?
- Can a few short nights of sleep tip the scales toward high blood pressure?
- Chatbot could put blood pressure control in Patients' hands
- Can a 5-Step chat help tame high blood pressure?
- Can artery scans reveal hidden damage from high blood pressure?
- CRISPR injection could rewrite the future of blood pressure control